Back to Search Start Over

Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma – Authors' reply

Authors :
Patricia, Pautier
Marie-Laure, Tanguy
Baptiste, Archambaud
Source :
The Lancet Oncology. 23:e445
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Leiomyosarcoma
Oncology
Doxorubicin
Humans
Trabectedin

Details

ISSN :
14702045
Volume :
23
Database :
OpenAIRE
Journal :
The Lancet Oncology
Accession number :
edsair.doi.dedup.....97d1669259a71a40e4ecb9aa24ac1219
Full Text :
https://doi.org/10.1016/s1470-2045(22)00563-0
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details